These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 16582795

  • 1. Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture.
    Seyhan H, Kopp J, Schultze-Mosgau S, Horch RE.
    Plast Reconstr Surg; 2006 Apr; 117(4):1248-52. PubMed ID: 16582795
    [Abstract] [Full Text] [Related]

  • 2. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA, Banducci DR, Graham WP, Allison GM, Ehrlich HP.
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [Abstract] [Full Text] [Related]

  • 3. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro.
    Moyer KE, Banducci DR, Graham WP, Ehrlich HP.
    Plast Reconstr Surg; 2002 Jul; 110(1):187-93; discussion 194-6. PubMed ID: 12087251
    [Abstract] [Full Text] [Related]

  • 4. The role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren's disease fibroblasts.
    Townley WA, Cambrey AD, Khaw PT, Grobbelaar AO.
    J Hand Surg Eur Vol; 2009 Dec; 34(6):783-7. PubMed ID: 19786408
    [Abstract] [Full Text] [Related]

  • 5. An insight into Dupuytren's contracture.
    Murrell GA.
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [Abstract] [Full Text] [Related]

  • 6. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord).
    Vande Berg JS, Gelberman RH, Rudolph R, Johnson D, Sicurello P.
    J Orthop Res; 1984 May; 2(3):247-56. PubMed ID: 6491814
    [Abstract] [Full Text] [Related]

  • 7. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1.
    Bisson MA, McGrouther DA, Mudera V, Grobbelaar AO.
    J Hand Surg Br; 2003 Aug; 28(4):351-6. PubMed ID: 12849947
    [Abstract] [Full Text] [Related]

  • 8. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture?
    Bisson MA, Mudera V, McGrouther DA, Grobbelaar AO.
    Plast Reconstr Surg; 2004 Feb; 113(2):611-21; discussion 622-4. PubMed ID: 14758224
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The myofibroblast in Dupuytren's contracture.
    Rudolph R, Vande Berg J.
    Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [Abstract] [Full Text] [Related]

  • 11. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
    Ulrich D, Ulrich F, Piatkowski A, Pallua N.
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
    [Abstract] [Full Text] [Related]

  • 12. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E, Taurone S, Bardella L, Signore A, Pompili E, Sessa V, Chiappetta C, Fumagalli L, Di Gioia C, Pastore FS, Scarpa S, Artico M.
    Clin Sci (Lond); 2015 Oct 01; 129(8):711-20. PubMed ID: 26201022
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat.
    Satish L, Palmer B, Liu F, Papatheodorou L, Rigatti L, Baratz ME, Kathju S.
    BMC Musculoskelet Disord; 2015 Jun 07; 16():138. PubMed ID: 26049932
    [Abstract] [Full Text] [Related]

  • 15. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
    Kuhn MA, Payne WG, Kierney PC, Pu LL, Smith PD, Siegler K, Ko F, Wang X, Robson MC.
    Int J Surg Investig; 2001 Jun 07; 2(6):443-56. PubMed ID: 12678125
    [Abstract] [Full Text] [Related]

  • 16. The collagen changes of Dupuytren's contracture.
    Murrell GA, Francis MJ, Bromley L.
    J Hand Surg Br; 1991 Aug 07; 16(3):263-6. PubMed ID: 1960490
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA, Beckett KS, McGrouther DA, Grobbelaar AO, Mudera V.
    J Hand Surg Am; 2009 Aug 07; 34(6):1102-10. PubMed ID: 19505772
    [Abstract] [Full Text] [Related]

  • 18. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
    Wong M, Mudera V.
    J Hand Surg Br; 2006 Oct 07; 31(5):473-83. PubMed ID: 16875762
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dupuytren's disease metabolite analyses reveals alterations following initial short-term fibroblast culturing.
    Rehman S, Xu Y, Dunn WB, Day PJ, Westerhoff HV, Goodacre R, Bayat A.
    Mol Biosyst; 2012 Sep 07; 8(9):2274-88. PubMed ID: 22772395
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.